El interés en corto de Bioceres Crop Solutions da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Bioceres Crop Solutions. Los datos de interés en corto se actualizan cada dos semanas.

Bioceres Crop Solutions (NASDAQ:BIOX) Bolsa, Informe de interés en corto

Bioceres Crop Solutions

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions Corp

BIOXYNE LTD by BIOXYNE LTD.

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics Inc

Bioxytran Inc

WIIM

Sprout Social shares are trading lower after the company issued Q1 and FY25 revenue guidance below estimates.

Macro Economic Events

Commodities

Economics

Markets

API Weekly Crude Oil Stock: 640K Barrel Draw vs 2.3M Barrel Build Est.

INVX

Innovex International shares are trading higher. The company reported Q4 financial results.

Diversified Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHC#NASDAQ">DHC</a>) reported quarterly earnings of $0.02 per share. This is a 33.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $379.62 million which beat the analyst consensus estimate of $370.97 million by 2.33 percent. This is a 5.00 percent increase over sales of $361.54 million the same period last year.

Earnings

Earnings Beats

News

Diversified Healthcare Q4 FFO $0.02 Down From $0.03 YoY, Sales $379.62M Beat $370.97M Estimate

Sila Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SILA#NYSE">SILA</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.53 by 1.89 percent. This is a 5.26 percent decrease over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $46.55 million which beat the analyst consensus estimate of $45.60 million by 2.07 percent. This is a 1.37 percent increase over sales of $45.91 million the same period last year.

SILA

Sila Realty Trust Q4 FFO $0.54 Beats $0.53 Estimate, Sales $46.55M Beat $45.60M Estimate

General

NGVT

Ingevity Says Business Portfolio Review Is Progressing With Recently Announced Strategic Alternatives

CCCS

CCC Intelligent Solutions shares are trading higher after the company reported better-than-expected Q4 revenue results and issued Q1 revenue guidance above estimates.

Goldman Sachs analyst Kash Rangan maintained a Buy rating and price forecast for MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) following the company's <a target="_blank" href="https://www.benzinga.com/quote/mdb/analyst-ratings" rel="noreferrer noopener">acquisition of Voyage AI on Monday</a>.
MongoDB&nbsp;told&nbsp;Bloomberg that the purchase consideration was $220 <a target="_blank" href="https://www.benzinga.com/media/25/02/43916988/mongodb-expands-ai-capabilities-with-voyage-ai-deal-targets-faster-insights-from-unstructured-data" rel="noreferrer noopener">million under a cash-and-stock deal</a>.
The analyst says that they believe that the buyout of Voyage AI will strengthen MongoDB&#8217;s AI product roadmap and position within the modern data stack.
This is mainly due to Voyage's advanced text embedding and reranking models, which enhance organizations&#8217; ability to create RAG-enabled AI applications with better contextual relevance, cost efficiency, and reduced latency, adds the analyst.
Rangan notes that Voyage&#8217;s flagship general-purpose and multilingual embedding model, voyage-3-large (released January 7, 2025), surpasses OpenAI-v3-large and Cohere-v3-English by an average of 9.74% and 20.71%, respectively, in retrieval quality, according to Voyage AI.
Additionally, Voyage AI&#8217;s voyage-3-large sets a new accuracy-cost benchmark, using advanced techniques like quantization-aware training and Matryoshka learning to reduce storage costs and processing times with minimal impact on retrieval quality, says the analyst.
Overall, the analyst views this as a valuable acquisition of both technology and talent for MongoDB, with Voyage's models (set for integration later this year) offering top-tier embedding models that provide performance and cost benefits, potentially fast-tracking AI production workloads on MongoDB's platform.
This aligns with the analyst&#8217;s expectation of 20%+ Atlas revenue growth in the near-to-medium term.
With Atlas now accounting for approximately 70% of revenue and consistently growing at over 20% since its launch, the analyst sees strong potential for sustained growth in the medium term and the ability to reach $6 billion-$8 billion+ in revenue in the long run.
Investors can gain exposure to the stock via TrueShares Technology, AI &amp; Deep Learning ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRNZ#NYSE">LRNZ</a>) and Sterling Capital Focus Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCG#NYSE">LCG</a>).
Price Action: MDB shares closed down by 2.77% at $259.71 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43942860/paypal-eyes-double-digit-eps-growth-by-2027-teams-up-with-verifone-jp-morgan-more" target="_blank" rel="noreferrer noopener">PayPal Eyes Double-Digit EPS Growth By 2027, Teams Up With Verifone, J.P. Morgan &amp; More</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Equities

Large Cap

Reiteration

Analyst Ratings

Movers

Tech

Trading Ideas

LRNZ

Voyage AI Acquisition Adds Advanced Tech, Talent to MongoDB's AI Capabilities: Analyst

Workiva shares are trading higher after the company reported better-than-expected Q4 revenue results and issued FY25 revenue guidance above estimates.

FLUX

Flux Power Receives Non-Compliance Notice From Nasdaq

Arcus Biosciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCUS#NYSE">RCUS</a>) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1.32) by 21.97 percent. This is a 4.63 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $36.00 million which beat the analyst consensus estimate of $28.90 million by 24.57 percent. This is a 16.13 percent increase over sales of $31.00 million the same period last year.

RCUS

Arcus Biosciences Q4 EPS $(1.03) Beats $(1.32) Estimate, Sales $36.00M Beat $28.90M Estimate

LMND

Lemonade shares are trading lower. The company reported Q4 financial results.

Carlyle Secured Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBD#NASDAQ">CGBD</a>) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.44 by 6.82 percent. This is a 16.07 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $56.35 million which beat the analyst consensus estimate of $55.10 million by 2.28 percent. This is a 10.10 percent decrease over sales of $62.69 million the same period last year.

CGBD

Carlyle Secured Lending Q4 Adj $0.47 Beats $0.44 Estimate, Sales $56.35M Beat $55.10M Estimate

Guidance

Innovex International Sees Q1 Revenue $245M-$255M

Workday, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) reported its fourth-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/02/n43956199/workday-announces-fiscal-2025-fourth-quarter-and-full-year-financial-results">details from the report.&nbsp;</a>
The Details:&nbsp;Workday reported quarterly earnings of&nbsp;$1.92&nbsp;per share which beat the analyst consensus estimate of&nbsp;$1.78. Quarterly revenue clocked in at $2.21 billion&nbsp;which beat the analyst consensus estimate of&nbsp;$2.18 billion&nbsp;and is an&nbsp;increase over revenue of&nbsp;$1.92 billion&nbsp;from the same period last year.
Workday reported subscription revenues were $2.04 billion, an increase of 15.9% year-over-year and operating income of $75 million, or 3.4% of revenues. 
Read Next:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43949800/tesla-competes-against-chinese-rivals-with-one-hand-tied-behind-its-back-analyst"> Tesla Competes Against Chinese Rivals &#8216;With One Hand Tied Behind Its Back&#8217;: Analyst</a>
&#8220;Our fourth quarter performance is a testament to Workday&#8217;s value proposition as organizations seek to boost productivity, run more efficiently, and deliver incredible employee experiences,&#8221; said Carl Eschenbach, CEO, Workday. 
&#8220;Workday&#8217;s unified platform gives customers the ultimate advantage—helping them unlock value faster, reduce total cost of ownership, and harness the power of AI across our best-in-class HR and finance solutions,&#8221; Eschenbach added. 
Outlook: Workday guided to first-quarter subscription revenue of $2.05 billion, representing growth of 13%, and non-GAAP operating margin of 28%. The company expects fiscal 2026 full year subscription revenue of $8.8 billion, representing growth of 14%, and non-GAAP operating margin of 28%.
WDAY Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Workday shares are up 7.3% after hours at $273.85&nbsp; Tuesday.&nbsp;&nbsp;
Read Next:<a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43951080/bitcoin-plunges-as-consumer-confidence-falls-whats-driving-markets-tuesday">Bitcoin Plunges As Consumer Confidence Falls: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Image: Shutterstock

After-Hours Center

WDAY

Workday Shares Climb After Q4 Report: Here's Why

QuickLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUIK#NASDAQ">QUIK</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is a 77.78 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $5.08 million which missed the analyst consensus estimate of $6.07 million by 16.35 percent. This is a 32.14 percent decrease over sales of $7.48 million the same period last year.

Earnings Misses

QUIK

QuickLogic Q4 Adj $0.04 Beats $0.03 Estimate, Sales $5.08M Miss $6.07M Estimate

Management

LCID

Lucid Group Appoints Peter Rawlinson Interim Chief Executive Officer

Innovex International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVX#NYSE">INVX</a>) reported $251.000 million in sales this quarter.

Innovex International Q4 Sales $251.000M

CPNG

Coupang shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.

AMC CEO Says 'Over the course of the year, AMC reduced its debt obligations by more than $375 million, and we ended the year with more than $630 million of available cash.'

Press Releases

Bioceres Crop Solutions Reports Fiscal Third Quarter 2024 Financial and Operational Results

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2024 Financial Results Conference Call on Tuesday, September 10, 2024 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions Receives Green Light for Cultivation of Drought Tolerant HB4 Wheat in the United States

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2024 Financial and Operational Results

Bioceres Crop Solutions to Host Fiscal First Quarter 2025 Financial Results Conference Call on Tuesday, November 12, 2024 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results

Bioceres Crop Solutions to Host Fiscal Second Quarter 2025 Financial Results Conference Call on Wednesday, February 12, 2025 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations

Bioceres Crop Solutions Reports Fiscal Second Quarter 2025 Financial and Operational Results

Health Care

Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration

BIOX

BTAX

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners

Canaccord Genuity

Lake Street

Oppenheimer

Roth MKM

Comments

Bioceres Crop Solutions

Interés en corto

Bioceres Crop Solutions (NASDAQ:BIOX) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL